Medical Health & Life Science Research News

Research report explores the biosimilars market forecast to 2021

Research report explores the biosimilars market forecast to 2021

The key players in the biosimilars market include Pfizer Inc. (U.S.), Sandoz International GmbH (Germany),Teva Pharmaceuticals Industries Ltd. (Israel),Amgen Inc. (U.S.), Biocon Ltd. (India), Dr. Reddy’s Laboratories Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), Celltrion Inc. (South Korea), and Samsung Bioepis (South Korea).

- Agency -.

Biosimilars Market will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. 

Get Sample Copy [email protected] www.rnrmarketresearch.com/contacts…mple?rname=130963

The global biosimilars market is expected to reach USD 10.90 billion by 2021 from USD 3.39 billion in 2016, at a CAGR of 26.3%. The biosimilars market is broadly classified into product, manufacturing type, application, and region.

On the basis of product, the biosimilars market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides.

- Agency -.

The recombinant non-glycosylated proteins segment is estimated to account for the largest share of the biosimilars market, in 2016.Factors such as new product launches, cost-effectiveness, growing incidence of diabetes, and presence of many biosimilar versions of insulin in the pipeline are driving growth in this market.

On the basis of manufacturing type, the market is segmented into in-house manufacturing and contract manufacturing organizations. The contract manufacturing organizations segment is projected to witness the highest CAGR during the forecast period.

Biosimilars Market by type 2017-2021 by new Service spreads across 152 pages profiling 10 companies and supported with 91 tables and 42 figures available at www.rnrmarketresearch.com/contacts…ount?rname=130963

Executive Summary
Introduction
Conclusion

Premium Insights
Biosimilars: Market Overview
Geographic Analysis: Biosimilars Market, By Product
Biosimilars Market Size, By Application, 2016 vs. 2021

Research Methodology
Secondary Data
Key Data From Secondary Sources
Primary Data
Key Data From Primary Sources
Biosimilars Market Size Estimation
Bottom-Up Approach
Top-Down Approach
Biosimilars Market Breakdown & Data Triangulation
Assumptions for the Study

Fundamental from table of content

11 Company Profiles

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, RnRmr View)*
11.1 Introduction
11.2 Pfizer Inc.
11.3 Sandoz International GmbH (A Division of Novartis International AG)
11.4 Teva Pharmaceutical Industries Ltd.
11.5 F. Hoffmann-La Roche Ltd.
11.6 Amgen Inc.
11.7 Biocon Ltd.
11.8 Dr. Reddy's Laboratories
11.9 Celltrion Inc.
11.10 Mylan Inc.
11.11 Samsung Bioepis 

*Details on RnRmr View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.